CompanyGraph
At a glance
- Depends onDownstream position: depends on 23 industries, supplies 5
- ScaleLevered free cash flow is $1.74B, higher than 95% of all stocks globally
- FinancialsHigh earnings quality
- Interpretations4 currently firing — 1 · 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.71%Below 5Y avg (0.82%)
Annual Rate
USD 0.08Paid quarterly
Payout Ratio
21.6%Sustainable
Consecutive Growth
2 yr
Paying Dividends
14 yr
Last Ex-Dividend
May 27, 2026
Last Payment
Jun 10, 2026
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
Buyback-to-OCF Elevated With Dividend Coverage-Stability Composite And 5-Year Buyback-to-Market-Cap Yield Elevated
→buyback intensity
dividend coverage and payment stability
share repurchase yield
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
Buyback-to-OCF Elevated With Dividend Coverage-Stability Composite And 5-Year Buyback-to-Market-Cap Yield Elevated
Buybacks take a large share of its cash flow, and it pays a dividend too.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.41BUSDvs all stocks (USD)
Trailing P/E
29.53xvs Capital Markets peers
Revenue (TTM)
3.10BUSDvs all stocks (USD)
Profit Margin
5.93%vs Capital Markets peers
Beta
0.9420xvs all stocks
52-Week Change
12.21%vs all stocks
Forward Annual Dividend Yield
0.71%vs all stocks
Market Capitalization
5.41BUSDvs all stocks (USD)
Enterprise Value
6.65BUSDvs all stocks (USD)
Trailing P/E
29.53xvs Capital Markets peers
Forward P/E
7.10xvs Capital Markets peers
PEG Ratio
0.5413xvs Capital Markets peers
Price to Sales (TTM)
1.73xvs Capital Markets peers
Price to Book (MRQ)
4.88xvs Capital Markets peers
Enterprise to Revenue
2.15xvs Capital Markets peers
Enterprise to EBITDA
17.70xvs Capital Markets peers
Gross Margin
39.99%vs Capital Markets peers
Profit Margin
5.93%vs Capital Markets peers
Operating Margin
12.07%vs Capital Markets peers
Return on Assets (TTM)
3.29%vs Capital Markets peers
Return on Equity (TTM)
14.62%vs Capital Markets peers
Revenue (TTM)
3.10BUSDvs all stocks (USD)
Revenue per Share (TTM)
6.52USDUpdated Jul 18, 2026Quarterly Revenue Growth
44.30%vs Capital Markets peers
Gross Profit (TTM)
2.84BUSDvs all stocks (USD)
EBITDA (TTM)
489.53MUSDvs all stocks (USD)
Net Income (TTM)
176.48MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
52.50%vs Capital Markets peers
Operating Cash Flow (TTM)
413.70MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
1.74BUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.0800USDUpdated Jul 18, 2026Forward Annual Dividend Yield
0.71%vs all stocks
Trailing Annual Dividend Rate
0.0800USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.71%vs all stocks
5-Year Average Dividend Yield
0.82%vs all stocks
Payout Ratio
21.62%vs Capital Markets peers
Minority Interest (Equity)
172.86MUSDFY2025 · Dec 31, 2025Revenue
2.89BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.76BUSDFY2025 · Dec 31, 2025Gross Profit
1.12BUSDFY2025 · Dec 31, 2025Operating Income
300.56MUSDvs all stocks (USD)
Pre-tax Income
213.75MUSDFY2025 · Dec 31, 2025Income Tax Expense
67.21MUSDFY2025 · Dec 31, 2025Net Income
146.54MUSDFY2025 · Dec 31, 2025EBIT
339.06MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
375.66MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
822.50MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
53.83MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
125.32MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
146.54MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
8.42MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
6.33MUSDFY2025 · Dec 31, 2025Operating Cash Flow
350.61MUSDFY2025 · Dec 31, 2025Free Cash Flow
329.12MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
873.67MUSDFY2025 · Dec 31, 2025Income Tax Paid
148.14MUSDFY2025 · Dec 31, 2025Interest Paid
109.42MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
146.54MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
103.31MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-15.04MUSDFY2025 · Dec 31, 2025Stock-based Compensation
329.59MUSDFY2025 · Dec 31, 2025Other Non-cash Items
152.75MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-316.61MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-66.17MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
16.25MUSDFY2025 · Dec 31, 2025Capital Expenditures
-21.49MUSDFY2025 · Dec 31, 2025Net Acquisitions
-194.65MUSDFY2025 · Dec 31, 2025Purchase of Investments
-21.01MUSDFY2025 · Dec 31, 2025Other Investing Activity
-953.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-238.10MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.44BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.00BUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
20.00MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-390.67MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-38.99MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.85MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
21.23MUSDFY2025 · Dec 31, 2025Shares Outstanding
478.88MSharesUpdated Jul 18, 2026Float Shares
366.59MSharesUpdated Jul 18, 2026Shares Short
9.04MSharesUpdated Jul 18, 2026Short Ratio
2.15daysvs all stocks
Short % of Shares Outstanding
2.87%vs all stocks
% Held by Insiders
0.85%vs all stocks
% Held by Institutions
83.58%vs all stocks
Total Cash (MRQ)
900.51MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.88USDUpdated Jul 18, 2026Total Debt (MRQ)
2.00BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.57xvs Capital Markets peers
Current Ratio (MRQ)
1.49xvs Capital Markets peers
Book Value per Share (MRQ)
2.30USDUpdated Jul 18, 2026Total Assets
4.41BUSDvs all stocks (USD)
Total Current Assets
2.36BUSDFY2025 · Dec 31, 2025Total Liabilities
3.27BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.05BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.15BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.11BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
851.50MUSDFY2025 · Dec 31, 2025Accounts Receivable
0.00USDFY2025 · Dec 31, 2025Accounts Payable
1.11MUSDFY2025 · Dec 31, 2025Short-term Debt
257.69MUSDFY2025 · Dec 31, 2025Long-term Debt
1.74BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
17.33MUSDFY2025 · Dec 31, 2025Common Stock (Book)
5.54MUSDFY2025 · Dec 31, 2025Retained Earnings
-910.39MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.15BUSDvs all stocks (USD)
Treasury Stock
614.53MUSDFY2025 · Dec 31, 202552-Week Low
8.27USDUpdated Jul 18, 202652-Week High
12.89USDUpdated Jul 18, 202652-Week Change
12.21%vs all stocks
Beta
0.9420xvs all stocks
50-Day MA
11.16USDUpdated Jul 18, 2026200-Day MA
9.87USDUpdated Jul 18, 2026Avg 10-Day Volume
2.63MSharesUpdated Jul 18, 2026Avg 30-Day Volume
3.72MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
0.3800USDUpdated Jul 18, 2026Other Income / Expense
-15.32MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.87
Supply Chain
Downstream position: depends on 23 industries, supplies 5Notable
Outgoing: 5.00Incoming: 23.00
High connectivity hub: 28 industry connectionsNotable
Total Connections: 28.00
Scale
Levered free cash flow is $1.74B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 1,735,353,000Global P95: 1,123,592,359.78
Market cap is $5.41B, above the global median of $1.15BNotable
Market cap (USD): 5,413,339,998Global Median: 1,146,734,693.424
Revenue is $3.1B, above the global median of $520.53MNotable
Revenue (USD): 3,099,585,024Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Tianfeng Securities Co., Ltd.
Tier 1InterfacePlatform IntermediationFlowRisk
Kiwoom Securities Co., Ltd.
Tier 1InterfacePlatform IntermediationFlowRisk
Auto Trader Group Plc
Tier 1InterfacePlatform IntermediationAttentionFlow
Capital Securities Co., Ltd.
Tier 1InterfacePlatform IntermediationFlowRisk
Netease Cloud Music Inc.
Tier 1InterfacePlatform IntermediationAttentionFlow
MakeMyTrip Limited
Tier 1InterfacePlatform IntermediationFlowSenseMaking
Chinalin Securities Co., Ltd.
Tier 1InterfacePlatform IntermediationFlowRisk
Piper Sandler Companies
Tier 1InterfacePlatform IntermediationFlowRisk
Rightmove plc
Tier 1InterfacePlatform IntermediationAttentionFlow
Moelis & Company
Tier 1InterfacePlatform IntermediationRiskSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Genpact Ltd.
4 interpretationsFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income GrowthBuyback-to-OCF Elevated With Dividend Coverage-Stability Composite And 5-Year Buyback-to-Market-Cap Yield ElevatedMulti-Year FCF With Growth And Margin
Harmony Biosciences Holdings, Inc.
3 interpretationsFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
IMI plc
3 interpretationsFCF Ratios ElevatedMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin